<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Научные результаты биомедицинских исследований</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2313-8955-2019-5-1-0-7</article-id><article-id pub-id-type="publisher-id">1611</article-id><article-categories><subj-group subj-group-type="heading"><subject>Клиническая медицина</subject></subj-group></article-categories><title-group><article-title>Сигнальные молекулы, вовлеченные в образование новых нервных окончаний при эндометриозе (обзор)</article-title><trans-title-group xml:lang="en"><trans-title>Signal molecules involved in the formation of new nerve endings in endometriosis (review)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Андреев</surname><given-names>Александр Евгеньевич</given-names></name><name xml:lang="en"><surname>Andreev</surname><given-names>Alexander E.</given-names></name></name-alternatives><email>alexander_597@mail.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Клейменова</surname><given-names>Татьяна Сергеевна</given-names></name><name xml:lang="en"><surname>Kleimenova</surname><given-names>Tatyana S.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Дробинцева</surname><given-names>Анна Олеговна</given-names></name><name xml:lang="en"><surname>Drobintseva</surname><given-names>Anna O.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Полякова</surname><given-names>Виктория Олеговна</given-names></name><name xml:lang="en"><surname>Polyakova</surname><given-names>Victoriya O.</given-names></name></name-alternatives><email>vopol@yandex.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Кветной</surname><given-names>Игорь Моисеевич</given-names></name><name xml:lang="en"><surname>Kvetnoy</surname><given-names>Igor M.</given-names></name></name-alternatives></contrib></contrib-group><pub-date pub-type="epub"><year>2019</year></pub-date><volume>5</volume><issue>1</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2019/1/Биомедицинские_иссл-95-108.pdf" /><abstract xml:lang="ru"><p>Актуальность: Механизм развития болевого синдрома при эндометриозе имеет гетерогенный характер. Установлено, что в недавно образовавшихся эндометриоидных имплантах идут процессы неонейрогенеза, заключающиеся в формировании малых сенсорных волокон с повышенной ноцептивной чувствительностью. Результатом этого становится повышенная болевая чувствительность пациенток, которая в совокупности с воспалительными процессами может приводить к развитию хронической тазовой боли. Цель исследования: Собрать и структурировать информацию, касательно молекулярных маркеров, прямо или косвенно участвующих в сигнальном каскаде фактора роста нервов. Материалы и методы: В обзор включены современные данные зарубежных и отечественных статей, найденные в Pubmed по данной теме. Результаты: В настоящем обзоре рассмотрены молекулярные механизмы работы в норме и при патологии фактора роста нервов, рецепторов к андрогену, ARID1A и периферина. Данные молекулярные маркеры участвуют в передаче сигнала по молекулярному каскаду, индицирующему образование новых нейронов с последующим развитием болевого синдрома при эндометриоидной болезни. Заключение: В обзоре охарактеризованы еще недостаточно исследованные маркеры, полученная информация должна способствовать лучшему понимаю процессов неонейрогенеза при эндометриозе для улучшения диагностики данного заболевания и лечения хронической тазовой боли. </p></abstract><trans-abstract xml:lang="en"><p>Background: The mechanism of the development of pain syndrome in endometriosis is heterogeneous. The study has been established that in the recently formed endometriotic implants there are neoneurogenesis processes, which consist in the formation of small sensory fibers with increased sensory sensitivity. This results in an increased pain sensitivity of patients, which, together with inflammatory processes, can lead to the development of chronic pelvic pain. The aim of the study: To collect and structure information regarding molecular markers directly or indirectly involved in the NGF signaling cascade. Materials and methods: The review includes modern data of foreign and domestic articles on this topic found in Pubmed. Results: This review examines the molecular mechanisms of work in healthy patients and in the pathology of the nerve growth factor, the androgen receptor, ARID1A, and peripherin. These molecular markers are involved in the signal transmission through the molecular cascade, which indicates the formation of new neurons, followed by the development of pain syndrome in endometriosis. Conclusion: In the review, there are still insufficiently studied markers, whose study is of interest for studying this issue. The information obtained should promote a better understanding of neo-neuronal processes in endometriosis to improve the diagnosis of this disease and to treat chronic pelvic pain.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>фактор роста нервов</kwd><kwd>рецептор к андрогену</kwd><kwd>ARID1A</kwd><kwd>перефирин</kwd><kwd>эндометриоз</kwd><kwd>хроническая тазовая боль</kwd><kwd>неонейрогенез</kwd></kwd-group><kwd-group xml:lang="en"><kwd>nerve growth factor</kwd><kwd>androgen receptor</kwd><kwd>ARID1A</kwd><kwd>peripherin</kwd><kwd>endometriosis</kwd><kwd>chronic pelvic pain</kwd><kwd>neoneurogenesis</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Пальцев М.А., Кветной И.М. Нейроиммуноэндокринология эндометрия. В кн: Руководство по нейроиммуноэндокринологии. 3-е изд. М: ЗАО &amp;ldquo;Шико&amp;rdquo;, 2014 . С. 438-533.</mixed-citation></ref><ref id="B2"><mixed-citation>Ярмолинская М.И., Айламазян Э.К. Генитальный эндометриоз. Различные грани проблемы. Спб.: Эко-Вектор, 2017. 615 с.</mixed-citation></ref><ref id="B3"><mixed-citation>Кузнецова И.В. Эндометриоз и тазовая боль // Эффективная фармакотерапия. Акушерство и гинекология. 2014 . N 3(35). C. 18-27.</mixed-citation></ref><ref id="B4"><mixed-citation>Stress During Development of Experimental Endometriosis Influences Nerve Growth and Disease Progression / M. Cuevas [et al.] // Reprod Sci. 2018. Vol. 25(3). P. 347-357. DOI: https://doi.org/10.1177/1933719117737846</mixed-citation></ref><ref id="B5"><mixed-citation>Mechanism of pain generation for endometriosis-associated pelvic pain / H. Kobayashi [et al.] &amp;nbsp;// Archives of Gynecology and Obstetrics. 2014. Vol. 289(1). P. 13-21. DOI: https://doi.org/10.1007/s00404-013-3049-8</mixed-citation></ref><ref id="B6"><mixed-citation>Important role of collective cell migration and nerve fiber density in the development of deep nodular endometriosis / R. Orellana [et al.] // Fertil Steril. 2017. Vol. 107(4). P. 987-995. DOI: https://doi.org/10.1016/j.fertnstert.2017.01.005</mixed-citation></ref><ref id="B7"><mixed-citation>Инновационный подход в оценке роли нейрогенеза, ангиогенеза и лимфангиогенеза в патогенезе наружного генитального эндометриоза / Т.С. Шевелева [и др.] // Акушерство и гинекология Санкт-Петербурга. 2017. N 1. C. 40-45.</mixed-citation></ref><ref id="B8"><mixed-citation>Wiesmann C., de Vos A.M. Nerve growth factor: structure and function // Cell Mol Life Sci. 2001. Vol. 58(5-6). P. 748-59.</mixed-citation></ref><ref id="B9"><mixed-citation>Bucci C., Alifano P., Cogli L. The Role of Rab Proteins in Neuronal Cells and in the Trafficking of Neurotrophin Receptors // Membranes. 2014. N 4. P. 642-677.</mixed-citation></ref><ref id="B10"><mixed-citation>Sun H.L., Jiang T. The structure of nerve growth factor in complex with lysophosphatidylinositol // Acta Crystallogr F Struct Biol Commun. 2015. Vol. 71(7). P. 906-12. DOI: https://doi.org/10.1107/S2053230X15008870</mixed-citation></ref><ref id="B11"><mixed-citation>Structure of mouse 7S NGF: a complex of nerve growth factor with four binding proteins / B. Bax [et al.] // Structure. 1997. Vol. 5(10). P. 1275-85. DOI: https://doi.org/10.1016/S0969-2126(97)00280-3</mixed-citation></ref><ref id="B12"><mixed-citation>Nerve growth factor: structure/function relationships / R.A. Bradshaw [et al.] // Protein Sci. 1994. Vol. 3(11). P. 1901-13.</mixed-citation></ref><ref id="B13"><mixed-citation>Kryzhanovskii S.A., Vititnova M.B. Cardiovascular effects of the nerve growth factor: An analytical review. Part I: NGF-mediated intracellular signaling pathways // Human Physiology. 2011. Vol. 37(2). P. 217-228. DOI: https://doi.org/10.1134/S0362119711020113</mixed-citation></ref><ref id="B14"><mixed-citation>Possible involvement of nerve growth factor in dysmenorrhea and dyspareunia associated with endometriosis / T. Kajitani [et al.] // Endocr J. 2013. Vol. 60(10). P. 1155-64. DOI: https://doi.org/10.1507/endocrj.EJ13-0027</mixed-citation></ref><ref id="B15"><mixed-citation>Nerve Growth Factor Is Associated With Sexual Pain in Women With Endometriosis / B. Peng [et al.] // Reprod Sci. 2018. Vol. 25(4). P. 540-549. DOI: https://doi.org/10.1177/1933719117716778</mixed-citation></ref><ref id="B16"><mixed-citation>Localization of TrkB and p75 receptors in peritoneal and deep infiltrating endometriosis: an immunohistochemical study / A. Dewanto [et al.] // Reprod Biol Endocrinol. 2016. Vol. 14(1). P. 1-13. DOI: https://doi.org/10.1186/s12958-016-0178-5</mixed-citation></ref><ref id="B17"><mixed-citation>The importance of neuronal growth factors in the ovary / S. Streiter [et al.] // MHR: Basic science of reproductive medicine. 2016. Vol. 22(1). P. 3-17. DOI: https://doi.org/10.1093/molehr/gav057</mixed-citation></ref><ref id="B18"><mixed-citation>Low molecular weight, non-peptidic agonists of TrkA receptor with NGF-mimetic activity / D. Scarpi [et al.] // Cell Death Dis. 2012. N 3. P. 1-13. DOI: https://doi.org/10.1038/cddis.2012.80</mixed-citation></ref><ref id="B19"><mixed-citation>Effect of siRNA against &amp;beta;-NGF on nerve fibers of a rat model with endometriosis / Y. Chen [et al.] // Reprod Sci. 2014. Vol. 21(3). P. 329-39. DOI: https://doi.org/10.1177/1933719113497279</mixed-citation></ref><ref id="B20"><mixed-citation>тестостерона в женском организме. Часть 1. Общая и возрастная эндокринология и физиология тестостерона у женщин / С.Ю. Калинченко [и др.] // ДОКТОР.РУ. 2015. N 14(115). С. 59-64.</mixed-citation></ref><ref id="B21"><mixed-citation>Дегтярь В.Т., Кушлинский Н.Е. Специфические свойства рецепторов андрогенов человека // Cибирский онкологический журнал. 2005. N 3(15). С. 58-67.</mixed-citation></ref><ref id="B22"><mixed-citation>Айламазян Э.К. Акушерство. 9-е изд., перераб. и доп. М.: ГЭОТАР-Медиа, 2015. 704 с.</mixed-citation></ref><ref id="B23"><mixed-citation>Castoria G., Auricchio F., Migliaccio A. Extranuclear partners of androgen receptor: at the crossroads of proliferation, migration, and neuritogenesis // FASEB J. 2017. Vol. 31(4). P. 1289-1300. DOI: https://doi.org/10.1096/fj.201601047R</mixed-citation></ref><ref id="B24"><mixed-citation>Expression of size-polymorphic androgen receptor (AR) gene in ovarian endometriosis according to the number of cytosine, adenine, and guanine (CAG) repeats in AR alleles / J. Fujimoto [et al.] // Steroids. 1999. Vol. 64(8). P. 526-9. DOI: https://doi.org/10.1016/S0039-128X(99)00025-2</mixed-citation></ref><ref id="B25"><mixed-citation>The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis / G. Grandi [et al.] // Gynecology Endocrinology. 2017. Vol. 33(9). P. 712-715. DOI: https://doi.org/10.1080/09513590.2017.1314458</mixed-citation></ref><ref id="B26"><mixed-citation>Simitsidellis I., Saunders P.T.K., Gibson D.A. Androgens and endometrium: New insights and new targets // Molecular Cell Endocrinology. 2018. Vol. 465(15). P. 48-60. DOI: https://doi.org/10.1016/j.mce.2017.09.022</mixed-citation></ref><ref id="B27"><mixed-citation>Steroid receptor levels and histology of endometriosis and adenomyosis / T. Tamaya [et al.] // Fertil Steril. 1979 Apr. Vol. 31(4). P. 396-400. DOI: https://doi.org/10.1016/S0015-0282 (16) 43935-X</mixed-citation></ref><ref id="B28"><mixed-citation>Androgen receptor cytosine, adenine, and guanine trinucleotide repeat polymorphism in Korean patients with endometriosis: A case-control study / J.J. Shin [et al.] // Eur. J. Obstet. Gynecol. Reprod. Biol. 2017. N 218. P. 1-4. DOI: https://doi.org/10.1016/j.ejogrb.2017.09.005</mixed-citation></ref><ref id="B29"><mixed-citation>Identification of Shared Molecular Signatures Indicate the Susceptibility of Endometriosis to Multiple Sclerosis / A. Katiyar [et al.] // Front Genet. 2018. N 9. P. 42. DOI: https://doi.org/10.3389/fgene.2018.00042</mixed-citation></ref><ref id="B30"><mixed-citation>Wang X., Haswell J.R., Roberts C.M.W. Molecular Pathways: SWI/SNF (BAF) complexes are frequently mutated in cancer&amp;mdash;mechanisms and potential therapeutic insights // Clinical cancer research: an official journal of the American Association for Cancer Research. 2014. Vol. 20(1). P. 21-27.</mixed-citation></ref><ref id="B31"><mixed-citation>Wu J.N., Roberts C.W.M. ARID1A Mutations in Cancer: Another Epigenetic Tumor Suppressor? // Cancer discovery. 2013. Vol. 3(1). P. 35-43. DOI: 10.1158/2159-8290.CD-12-0361</mixed-citation></ref><ref id="B32"><mixed-citation>Helming K.C., Wang X., Roberts C.W.M. Vulnerabilities of mutant SWI/SNF complexes in cancer // Cancer cell. 2014. Vol. 26(3). P. 309-317. DOI: https://doi.org/10.1016/j.ccr.2014.07.018</mixed-citation></ref><ref id="B33"><mixed-citation>Wu R.C., Wang T.L., Shih I.M. The emerging roles of ARID1A in tumor suppression // Cancer Biology &amp;amp; Therapy. 2014. Vol. 15(6). P. 655-664. DOI: https://doi.org/10.4161/cbt.28411</mixed-citation></ref><ref id="B34"><mixed-citation>Cancer-Associated Mutations in Endometriosis without Cancer / M.S. Anglesio [et al.] // The New England journal of medicine. 2017. Vol. 376(19). P. 1835-1848. DOI: 10.1056/NEJMoa1614814</mixed-citation></ref><ref id="B35"><mixed-citation>ARID1A Expression is Down-Regulated by Oxidative Stress in Endometriosis and Endometriosis-Associated Ovarian Cancer / H. Winarto [et al.] // Translational Oncogenomics. 2017. N 9. P. 1-7. DOI: 10.1177 / 1177272716689818</mixed-citation></ref><ref id="B36"><mixed-citation>Loss of BAF250a (ARID1A) in rectovaginal deep-infiltrating endometriosis, endometriomas and involved pelvic sentinel lymph nodes / G.M. Borrelli [et al.] // MHR: Basic science of reproductive medicine. 2016. Vol. 22(5). P. 329-337. DOI: https://doi.org/10.1093/molehr/gaw009</mixed-citation></ref><ref id="B37"><mixed-citation>Mao T.-L., Shih I.-M. The roles of ARID1A in gynecologic cancer // Journal of Gynecologic Oncology. 2013. Vol. 24(4). P. 376-381. DOI: https://doi.org/10.3802/jgo.2013.24.4.376&amp;nbsp;</mixed-citation></ref><ref id="B38"><mixed-citation>ARID1A gene mutation in ovarian and endometrial cancers / T. Takeda [et al.] // Oncology Reports. 2016. Vol. 35(2). P. 607-613. DOI: https://doi.org/10.3892/or.2015.4421</mixed-citation></ref><ref id="B39"><mixed-citation>ARID1A Mutations and PI3K/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian Carcinomas / E.P. Samartzis [et al.] // International Journal of Molecular Sciences. 2013. Vol. 14(9). P.18824-18849. DOI: 10.3390/ijms140918824</mixed-citation></ref><ref id="B40"><mixed-citation>Hol E.M., Capetanaki Y. Type III Intermediate Filaments Desmin, Glial Fibrillary Acidic Protein (GFAP), Vimentin, and Peripherin // Cold Spring Harb Perspect Biol. 2017. Vol. 9(12). P. 1-18.</mixed-citation></ref><ref id="B41"><mixed-citation>Zhao J., Liem R.K.H. &amp;alpha;-Internexin and Peripherin: Expression, Assembly, Functions, and Roles in Disease // Methods Enzymol. 2016. N 568. P. 477-507. DOI: https://doi.org/10.1016/bs.mie.2015.09.012</mixed-citation></ref><ref id="B42"><mixed-citation>Peripherin and neurofilaments: expression and role during neural development / M.M. Portier [et al.] // C R Acad Sci III. 1993 Sep. Vol. 316(9). P. 1124-40.</mixed-citation></ref><ref id="B43"><mixed-citation>EP2 receptor antagonism reduces peripheral and central hyperalgesia in a preclinical mouse model of endometriosis / E. Greaves [et al.] // Scientific Reports. 2017. N 7. P. 1-10. DOI: https://doi.org/10.1038/srep44169</mixed-citation></ref><ref id="B44"><mixed-citation>Whole genome deoxyribonucleic acid microarray analysis of gene expression in ectopic versus eutopic endometrium / K.M. Eyster [et al.] // Fertil Steril. 2007 Dec. Vol. 88(6). P. 1505-33. DOI: https://doi.org/10.1016/j.fertnstert.2007.01.056</mixed-citation></ref><ref id="B45"><mixed-citation>ALS mouse model SOD1G93A displays early pathology of sensory small fibers associated to accumulation of a neurotoxic splice variant of peripherin / J. Sassone [et al.] // Human Molecular Genetics. 2016. Vol. 25(8). P. 1588-1599. DOI: https://doi.org/10.1093/hmg/ddw035</mixed-citation></ref></ref-list></back></article>